P
Philip C. Calder
Researcher at University of Southampton
Publications - 808
Citations - 70822
Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis.
Panayiotis Aristotelous,Manos Stefanakis,Marios Pantzaris,Constantinos S. Pattichis,Philip C. Calder,Philip C. Calder,Philip C. Calder,Ioannis Patrikios,Giorgos K. Sakkas,Giorgos K. Sakkas,Christoforos D. Giannaki +10 more
TL;DR: In this paper, the effect of a 24-month supplementation with a cocktail dietary supplement formula, the NeuroaspisTM PLP10, containing specific omega-3 and omega-6 PUFAs and specific antioxidant vitamins on gait and functional capacity parameters of patients with MS was examined.
Journal ArticleDOI
Ingestion, Immunity, and Infection: Nutrition and Viral Respiratory Tract Infections
TL;DR: The effects of a range different dietary components on anti-infective innate as well as adaptive immune responses are described and mechanisms by which they may interact with the immune system in the respiratory tract are proposed.
Journal ArticleDOI
Conjugated linoleic acid and human health-related outcomes
Parveen Yaqoob,Sabine Tricon,Christine M. Williams,Robert F. Grimble,Graham C. Burdge,Philip C. Calder +5 more
TL;DR: A recent study examined the separate effects of near-pure cis-9,trans-11 CLA (c9,t11 CLA) or trans-10,cis-12 CLA (t 10,c12 CLA) on health-related outcomes in healthy young males.
Journal ArticleDOI
Dysregulation of Subcutaneous White Adipose Tissue Inflammatory Environment Modelling in Non-Insulin Resistant Obesity and Responses to Omega-3 Fatty Acids – A Double Blind, Randomised Clinical Trial
Helena L. Fisk,Caroline E. Childs,Elizabeth A. Miles,Rob Ayres,Paul S. Noakes,Carolina Paras-Chavez,Elie Antoun,Karen A. Lillycrop,Philip C. Calder +8 more
TL;DR: It is concluded that a higher dose or longer duration of LC n-3 PUFA intervention may be needed to reduce obesity-associated scWAT inflammation and promote tissue homeostasis.
Journal ArticleDOI
Editorial: Omega-3 fatty acids and cardiovascular outcomes: an update.
TL;DR: This article will describe and discuss recent publications of important new cohort studies, meta-analyses favouring a mortality benefit of EPA and DHA, and statements regarding clinical practice that were published around that time.